Showing 1 - 2 results of 2 for search 'John M. Slopis', query time: 0.02s Refine Results
  1. 1
    Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial

    Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial by John M. Slopis, Octavio Arevalo, Cynthia S. Bell, Adelaide A. Hebert, Hope Northrup, Roy F. Riascos, Joshua A. Samuels, Keri C. Smith, Patti Tate, Mary Kay Koenig

    Published 2018-10-01
    Get full text
    Article
  2. 2
    Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosis?

    Immune Effector Cell Associated Neurotoxicity (ICANS) in Pediatric and Young Adult Patients Following Chimeric Antigen Receptor (CAR) T-Cell Therapy: Can We Optimize Early Diagnosi... by Brandon Douglas Brown, Francesco Paolo Tambaro, Francesco Paolo Tambaro, Mira Kohorst, Mira Kohorst, Linda Chi, Kris Michael Mahadeo, Kris Michael Mahadeo, Priti Tewari, Priti Tewari, Demetrios Petropoulos, Demetrios Petropoulos, John M. Slopis, Zsila Sadighi, Sajad Khazal, Sajad Khazal

    Published 2021-03-01
    Get full text
    Article

Search Tools: